Table I.
Characteristics of cohort
| Mean age at transplant (SD, median) | 51.6 (12.4, 53.8) |
| Gender, n (%) | |
| M | 939 (62.6%) |
| F | 560 (37.4%) |
| Transplanted organ type, n (%) | |
| Heart | 233 (15.5%) |
| Lung | 129 (8.6%) |
| Kidney | 633 (42.2%) |
| Liver | 504 (33.6%) |
| SUNTRAC group, n (%) | |
| Low risk | 0 |
| Medium risk | 847 (56.5%) |
| High risk | 636 (42.4%) |
| Very high risk | 16 (1.1%) |
| Skin cancer, n (%) | |
| Any skin cancer | 197 (13.1%) |
| cSCC | 109 (7.3%) |
| BCC | 71 (4.7%) |
| Melanoma | 10 (0.7%) |
| Other and unknown | 44 (2.9%) |
| HLA | |
| Low risk | 752 (50.2%) |
| High risk∗ | 747 (49.8%) |
BCC, Basal cell carcinoma; cSCC, cutaneous squamous cell carcinoma; HLA, human leukocyte antigen; SUNTRAC, Skin and Ultraviolet Neoplasia Transplant Risk Assessment Calculator.
∗
High risk HLA included HLA DPB1∗18, HLA DPB1∗1801, HLA DRB1∗0103, HLA DPB1∗16, HLA DPB1∗1601, HLA C∗01, HLA C∗0102, HLA A∗2501, HLA B∗27, HLA B∗1501, HLA C∗0702, HLA B∗07.